Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2013-04-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.1304502110PMID 23559371PMCID PMC3637757
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• POSTER PRESENTATION Open Access

  2013cited by this paper
• Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

  2012cited by this paper
• Increased survival with enzalutamide in prostate cancer after chemotherapy.

  2012cited by this paper
• Distinct patterns of dysregulated expression of enzymes involved in androgen synthesis and metabolism in metastatic prostate cancer tumors.

  2012cited by this paper
• The Mutational Landscape of Lethal Castrate Resistant Prostate Cancer

  2012cited by this paper
• Abiraterone and increased survival in metastatic prostate cancer.

  2011cited by this paper
• The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo

  2011influential reference
• Tumor Suppressor Role for the SPOP Ubiquitin Ligase in Signal-Dependent Proteolysis of the Oncogenic Coactivator SRC-3/AIB1

  2011influential reference
• Genotype-dependent sensitivity of uveal melanoma cell lines to inhibition of B-Raf, MEK, and Akt kinases: rationale for personalized therapy.

  2011cited by this paper
• Integrative genomic profiling of human prostate cancer.

  2010cited by this paper
• The genomic complexity of primary human prostate cancer

  2010cited by this paper
• Diverse somatic mutation patterns and pathway alterations in human cancers.

  2010cited by this paper
• Structures of SPOP-substrate complexes: insights into molecular architectures of BTB-Cul3 ubiquitin ligases.

  2009influential reference
• Nuclear receptor coregulators in cancer biology.

  2009cited by this paper
• Distinct genomic aberrations associated with ERG rearranged prostate cancer

  2009cited by this paper
• Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family

  2009cited by this paper
• Multiple Ser/Thr-rich degrons mediate the degradation of Ci/Gli by the Cul3-HIB/SPOP E3 ubiquitin ligase

  2009cited by this paper
• Coactivator selective regulation of androgen receptor activity.

  2009cited by this paper
• Coordinated Activation of the Nuclear Ubiquitin Ligase Cul3-SPOP by the Generation of Phosphatidylinositol 5-Phosphate*

  2008influential reference
• Essential phosphatases and a phospho-degron are critical for regulation of SRC-3/AIB1 coactivator function and turnover.

  2008cited by this paper
• Steroid receptor coactivator-3/AIB1 promotes cell migration and invasiveness through focal adhesion turnover and matrix metalloproteinase expression.

  2008cited by this paper
• SRC-3 coactivator functional lifetime is regulated by a phospho-dependent ubiquitin time clock.

  2007cited by this paper
• Targeting BRAFV600E in thyroid carcinoma: therapeutic implications

  2007cited by this paper
• The SRC-3/AIB1 coactivator is degraded in a ubiquitin- and ATP-independent manner by the REGgamma proteasome.

  2006cited by this paper
• The SRC-3/AIB1 Coactivator Is Degraded in a Ubiquitin- and ATP-Independent Manner by the REGγ Proteasome

  2006cited by this paper
• Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer.

  2006cited by this paper
• BTB Domain-containing Speckle-type POZ Protein (SPOP) Serves as an Adaptor of Daxx for Ubiquitination by Cul3-based Ubiquitin Ligase*

  2006cited by this paper
• Steroid receptor coactivator-3 and activator protein-1 coordinately regulate the transcription of components of the insulin-like growth factor/AKT signaling pathway.

  2006cited by this paper
• Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression.

  2005cited by this paper
• SRC-3 is required for prostate cancer cell proliferation and survival.

  2005cited by this paper
• Role of the Steroid Receptor Coactivator SRC-3 in Cell Growth

  2003cited by this paper
• Analysis of Protein Ubiquitination

  2002cited by this paper
• Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system

  1999cited by this paper
• Immunoprecipitation

  1998cited by this paper
• An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter.

  1997influential reference

• CD47 destabilization via manipulating the SPOP-USP2 axis augments macrophage phagocytosis and cancer immunotherapy

  2026cites this paper
• Outcomes for Patients With SPOP Mutated Castration-Resistant Prostate Cancer (CRPC) Treated With an Androgen Receptor Pathway Inhibitor (ARPI).

  2026cites this paper
• Molecular insights for the tumor suppressor role of SPOP in prostate cancer.

  2026cites this paper
• Functional dissection of SPOP on the amino acid level reveals a comprehensive functional landscape of variants during tumorigenesis

  2026cites this paper
• Systematic Characterization of Cancer‐Associated SPOP Mutants Reveals Novel and Reprogrammable Degradative Activities

  2026cites this paper
• VADEr: Vision Transformer-Inspired Framework for Polygenic Risk Reveals Underlying Genetic Heterogeneity in Prostate Cancer

  2025cites this paper
• Cul3 substrate adaptor SPOP targets Nup153 for degradation

  2025cites this paper
• The equilibrium between two quaternary assembly states determines the activity of SPOP and its cancer mutants

  2025cites this paper
• Germline–Somatic Liaison Dictates Cancer Subtypes via de novo Steroid Biosynthesis

  2025cites this paper
• Integrative Multi-Omics Analysis and Experimental Validation Identify SPOP as a Prognostic Biomarker and Immune Regulator in Lung Adenocarcinoma

  2025cites this paper
• Challenges and opportunities for the diverse substrates of SPOP E3 ubiquitin ligase in cancer

  2025cites this paper
• SPOP-dependent destabilization of SYT12 in a GSK-3β-dependent manner in papillary thyroid cancer cells

  2025cites this paper
• Cancer-associated SPOP mutations enlarge nuclear size and facilitate nuclear envelope rupture upon farnesyltransferase inhibitor treatment

  2025cites this paper
• Systematic characterization of cancer-associated SPOP mutants reveals novel and reprogrammable degradative activities

  2025cites this paper
• TRIM24-mediated K27-linked ubiquitination of ULK1 alleviates energy stress-induced autophagy and promote prostate cancer growth in the context of SPOP mutation.

  2025cites this paper
• The tripartite motif-containing 24 is a multifunctional player in human cancer

  2024cites this paper
• Exploring androgen receptor signaling pathway in prostate cancer: A path to new discoveries

  2024cites this paper
• Combination therapies with Wnt signaling inhibition: A better choice for prostate cancer treatment.

  2024cites this paper
• Efficacy and Predictive Factors Analysis of Androgen Deprivation Plus Novel Hormone Therapy as Neoadjuvant Treatment for High‐Risk Prostate Cancer

  2024cites this paper
• Deficiency in SPOP-mediated ubiquitination and degradation of TIAM1 promotes gastric cancer progression.

  2024cites this paper
• The Mutational and Transcriptional Landscapes of Speckle-Type POZ Protein (SPOP) and Androgen Receptor (AR) in a Single-Center pT3 Prostatectomy Cohort.

  2024cites this paper
• SPOP point mutations regulate substrate preference and affect its function

  2024cites this paper
• Prevalence of SPOP and IDH Gene Mutations in Prostate Cancer in a Jordanian Population

  2024cites this paper
• Function of Steroid Receptor Coactivators in T Cells and Cancers: Implications for Cancer Immunotherapy.

  2024cites this paper
• Editorial Comment on Exploring androgen receptor signaling pathway in prostate cancer: A path to new discoveries

  2024cites this paper
• Deciphering the genetic and epigenetic architecture of prostate cancer.

  2024cites this paper
• Androgen Receptor–Interacting Proteins in Prostate Cancer Development and Therapy Resistance

  2023cites this paper
• Zebrafish spop promotes ubiquitination and degradation of mavs to suppress antiviral response via the lysosomal pathway.

  2023cites this paper
• Opposing Roles of SPOP Mutations in Human Prostate and Endometrial Cancers

  2023cites this paper
• SPOP mutations target STING1 signaling in prostate cancer and create therapeutic vulnerabilities to PARP inhibitor-induced growth suppression.

  2023cites this paper
• Cul3 substrate adaptor SPOP targets Nup153 for degradation

  2023cites this paper
• Inflammation in Prostate Cancer: Exploring the Promising Role of Phenolic Compounds as an Innovative Therapeutic Approach

  2023cites this paper
• Genetic, Genomic, and Heritable Components of Benign Prostatic Hyperplasia

  2023cites this paper
• Higher-order SPOP assembly reveals a basis for cancer mutant dysregulation.

  2023cites this paper
• LRP5 competes for SPOP binding to enhance tumorigenesis mediated by Daxx and PD-L1 in prostate cancer.

  2023cites this paper
• Function, mechanism and drug discovery of ubiquitin and ubiquitin-like modification with multiomics profiling for cancer therapy

  2023cites this paper
• Biomarkers in Urinary Tract and Male Genital System Carcinomas

  2022cites this paper
• Prostate Cancer Epigenetic Plasticity and Enhancer Heterogeneity: Molecular Causes, Consequences and Clinical Implications.

  2022cites this paper
• SPOP mutations promote p62/SQSTM1-dependent autophagy and Nrf2 activation in prostate cancer

  2022cites this paper
• Deregulation of SPOP in cancer.

  2022cites this paper
• The E3 Ligases in Cervical Cancer and Endometrial Cancer

  2022cites this paper
• SPOP in Cancer: Phenomena, Mechanisms and Its Role in Therapeutic Implications

  2022cites this paper
• Race and prostate cancer: genomic landscape

  2022cites this paper
• Functional roles of E3 ubiquitin ligases in prostate cancer

  2022cites this paper
• Homing in on a moving target: Androgen Receptor cistromic plasticity in prostate cancer.

  2022cites this paper
• Conformational and oligomeric states of SPOP from small-angle X-ray scattering and molecular dynamics simulations

  2022cites this paper
• The evolving landscape of prostate cancer somatic mutations

  2022cites this paper
• Molecular mechanisms and genetic alterations in prostate cancer: From diagnosis to targeted therapy.

  2022cites this paper
• Analyzing the Androgen Receptor Interactome in Prostate Cancer: Implications for Therapeutic Intervention

  2022cites this paper
• Precision Targets for Intercepting the Lethal Progression of Prostate Cancer: Potential Avenues for Personalized Therapy

  2022cites this paper
• G3BP1 modulates SPOP to promote prostate tumorigenesis

  2022cites this paper
• Developing New Treatment Options for Castration-Resistant Prostate Cancer and Recurrent Disease

  2022cites this paper
• Novel insights into the SPOP E3 ubiquitin ligase: From the regulation of molecular mechanisms to tumorigenesis.

  2022cites this paper
• ERK1/2 inhibits Cullin 3/SPOP-mediated PrLZ ubiquitination and degradation to modulate prostate cancer progression

  2022cites this paper
• Racial disparities in prostate cancer: A complex interplay between socioeconomic inequities and genomics

  2022cites this paper
• Ubiquitin–proteasome system and the role of its inhibitors in cancer therapy

  2021cites this paper
• SPOP mutation confers sensitivity to AR-targeted therapy in prostate cancer by reshaping the androgen-driven chromatin landscape

  2021cites this paper
• An Immunosensor for the Detection of Speckle-type Poz Domain Protein Based on Pioneering Jasmine-like Cu@l-asp Hybrid Nanoflowers and Palladium-platinum Nanoparticles.

  2021cites this paper
• G3BP1 inhibits Cul3SPOP to amplify AR signaling and promote prostate cancer

  2021cites this paper
• GLI3 Is Stabilized by SPOP Mutations and Promotes Castration Resistance via Functional Cooperation with Androgen Receptor in Prostate Cancer

  2021cites this paper
• Gene polymorphism-related differences in the outcomes of abiraterone for prostate cancer: a systematic overview.

  2021cites this paper
• Inhibition of GATA2 in prostate cancer by a clinically available small molecule

  2021cites this paper
• Comprehensive analysis of tumour mutational burden and its clinical significance in prostate cancer

  2021cites this paper
• The nuclear ubiquitin ligase adaptor SPOP is a conserved regulator of C9orf72 dipeptide toxicity

  2021cites this paper
• Mutated SPOP E3 Ligase Promotes 17βHSD4 Protein Degradation to Drive Androgenesis and Prostate Cancer Progression

  2021cites this paper
• Clinical and genomic features of SPOP‐mutant prostate cancer

  2021cites this paper
• Reshaping of the androgen-driven chromatin landscape in normal prostate cells by early cancer drivers and effect on therapeutic sensitivity

  2021cites this paper
• SPOP mutation induces DNA methylation via stabilizing GLP/G9a

  2021cites this paper
• Transcriptional regulation and ubiquitination-dependent regulation of HnRNPK oncogenic function in prostate tumorigenesis

  2021cites this paper
• SPOP-mediated ubiquitination and degradation of PDK1 suppresses AKT kinase activity and oncogenic functions

  2021cites this paper
• Emerging Roles of Liquid–Liquid Phase Separation in Cancer: From Protein Aggregation to Immune-Associated Signaling

  2021cites this paper
• Androgen Receptor Signaling in Prostate Cancer Genomic Subtypes

  2021cites this paper
• Src-1 and SP2 promote the proliferation and epithelial–mesenchymal transition of nasopharyngeal carcinoma

  2021cites this paper
• Aberrant phase separation and cancer

  2021cites this paper
• The establishment of an immunosensor for the detection of SPOP

  2021cites this paper
• SPOP mutation induces replication over-firing by impairing Geminin ubiquitination and triggers replication catastrophe upon ATR inhibition

  2021cites this paper
• ATM-phosphorylated SPOP contributes to 53BP1 exclusion from chromatin during DNA replication

  2021cites this paper
• Somatic Alterations Impact AR Transcriptional Activity and Efficacy of AR-Targeting Therapies in Prostate Cancer

  2021cites this paper
• SPOP Deregulation Improves the Radiation Response of Prostate Cancer Models by Impairing DNA Damage Repair

  2020cites this paper
• Activator of thyroid and retinoid receptor increases sorafenib resistance in hepatocellular carcinoma by facilitating the Warburg effect

  2020cites this paper
• Association of SPOP Mutations with Outcomes in Men with De Novo Metastatic Castration-sensitive Prostate Cancer.

  2020cites this paper
• The diverse roles of SPOP in prostate cancer and kidney cancer

  2020cites this paper
• SPOP promotes ubiquitination and degradation of LATS1 to enhance kidney cancer progression

  2020cites this paper
• Phosphorylation of steroid receptor coactivator-3 (SRC-3) at serine 857 is regulated by the p38MAPK-MK2 axis and affects NF-κB-mediated transcription

  2020cites this paper
• Divergent Modulation of Proteostasis in Prostate Cancer.

  2020cites this paper
• De Novo Variants in SPOP Cause Two Clinically Distinct Neurodevelopmental Disorders.

  2020cites this paper
• E3 Ubiquitin Ligase APC/CCdh1 Regulation of Phenylalanine Hydroxylase Stability and Function

  2020cites this paper
• Hypomorph Mutation-Directed Small-Molecule Protein-Protein Interaction Inducers to Restore Mutant SMAD4-Suppressed TGF-β Signaling.

  2020cites this paper
• Clinical Actionability of the Genomic Landscape of Metastatic Castration Resistant Prostate Cancer

  2020cites this paper
• Key pathways in prostate cancer with SPOP mutation identified by bioinformatic analysis

  2020cites this paper
• SPOP and cancer: a systematic review.

  2020influential citation
• The role of ubiquitination in tumorigenesis and targeted drug discovery

  2020cites this paper
• Molecular Interplay between AURKA and SPOP Dictates CRPC Pathogenesis via Androgen Receptor

  2020cites this paper
• The Effect of Dysfunctional Ubiquitin Enzymes in the Pathogenesis of Most Common Diseases

  2020cites this paper
• The emerging role of SPOP protein in tumorigenesis and cancer therapy

  2020cites this paper
• Dual functions of SPOP and ERG dictate androgen therapy responses in prostate cancer

  2020cites this paper
• Immunotherapy for Metastatic Prostate Cancer: Current and Emerging Treatment Options.

  2020cites this paper
• CHD1 and SPOP synergistically protect prostate epithelial cells from DNA damage

  2020cites this paper
• Cullin 3 and Its Role in Tumorigenesis.

  2020cites this paper
• Proteostasis and Disease: From Basic Mechanisms to Clinics

  2020cites this paper